377 related articles for article (PubMed ID: 31832306)
41. Recent advances in non-plasmonic surface-enhanced Raman spectroscopy nanostructures for biomedical applications.
Li D; Aubertin K; Onidas D; Nizard P; Félidj N; Gazeau F; Mangeney C; Luo Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1795. PubMed ID: 35362261
[TBL] [Abstract][Full Text] [Related]
42. Cancer Stem Cell Derived Extracellular Vesicles with Self-Functionalized 3D Nanosensor for Real-Time Cancer Diagnosis: Eliminating the Roadblocks in Liquid Biopsy.
Haldavnekar R; Venkatakrishnan K; Tan B
ACS Nano; 2022 Aug; 16(8):12226-12243. PubMed ID: 35968931
[TBL] [Abstract][Full Text] [Related]
43. Nanostructured plasmonic substrates for use as SERS sensors.
Jeon TY; Kim DJ; Park SG; Kim SH; Kim DH
Nano Converg; 2016; 3(1):18. PubMed ID: 28191428
[TBL] [Abstract][Full Text] [Related]
44. Surface-Enhanced Raman Spectroscopy in Cancer Diagnosis, Prognosis and Monitoring.
Guerrini L; Alvarez-Puebla RA
Cancers (Basel); 2019 May; 11(6):. PubMed ID: 31146464
[TBL] [Abstract][Full Text] [Related]
45. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
[TBL] [Abstract][Full Text] [Related]
46. Tunable and Linker Free Nanogaps in Core-Shell Plasmonic Nanorods for Selective and Quantitative Detection of Circulating Tumor Cells by SERS.
Zhang Y; Yang P; Habeeb Muhammed MA; Alsaiari SK; Moosa B; Almalik A; Kumar A; Ringe E; Khashab NM
ACS Appl Mater Interfaces; 2017 Nov; 9(43):37597-37605. PubMed ID: 28990755
[TBL] [Abstract][Full Text] [Related]
47. Current strategies of plasmonic nanoparticles assisted surface-enhanced Raman scattering toward biosensor studies.
Zhou Y; Lu Y; Liu Y; Hu X; Chen H
Biosens Bioelectron; 2023 May; 228():115231. PubMed ID: 36934607
[TBL] [Abstract][Full Text] [Related]
48. Recent Advances in Engineered Noble Metal Nanomaterials as a Surface-Enhanced Raman Scattering Active Platform for Cancer Diagnostics.
Chen Y; Yu F; Wang Y; Liu W; Ye J; Xiao J; Liu X; Jiang H; Wang X
J Biomed Nanotechnol; 2022 Jan; 18(1):1-23. PubMed ID: 35180897
[TBL] [Abstract][Full Text] [Related]
49. Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications.
Wu S; Li R; Jiang Y; Yu J; Zheng J; Li Z; Li M; Xin K; Wang Y; Xu Z; Li S; Chen X
Biomed Pharmacother; 2023 Sep; 165():115027. PubMed ID: 37354812
[TBL] [Abstract][Full Text] [Related]
50. Advancements and Applications of Liquid Biopsies in Oncology: A Narrative Review.
Noor J; Chaudhry A; Noor R; Batool S
Cureus; 2023 Jul; 15(7):e42731. PubMed ID: 37654932
[TBL] [Abstract][Full Text] [Related]
51. Spatially Engineered Janus Hybrid Nanozyme toward SERS Liquid Biopsy at Nano/Microscales.
Su Y; Zhang Q; Miao X; Wen S; Yu S; Chu Y; Lu X; Jiang LP; Zhu JJ
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41979-41987. PubMed ID: 31621282
[TBL] [Abstract][Full Text] [Related]
52. Plasmonic surface-enhanced Raman scattering nano-substrates for detection of anionic environmental contaminants: Current progress and future perspectives.
Kitaw SL; Birhan YS; Tsai HC
Environ Res; 2023 Mar; 221():115247. PubMed ID: 36640935
[TBL] [Abstract][Full Text] [Related]
53. Recent Advances in Exosomal Protein Detection Via Liquid Biopsy Biosensors for Cancer Screening, Diagnosis, and Prognosis.
Liu C; Yang Y; Wu Y
AAPS J; 2018 Mar; 20(2):41. PubMed ID: 29520676
[TBL] [Abstract][Full Text] [Related]
54. Enhancing Nonfouling and Sensitivity of Surface-Enhanced Raman Scattering Substrates for Potent Drug Analysis in Blood Plasma via Fabrication of a Flexible Plasmonic Patch.
Masterson AN; Hati S; Ren G; Liyanage T; Manicke NE; Goodpaster JV; Sardar R
Anal Chem; 2021 Feb; 93(4):2578-2588. PubMed ID: 33432809
[TBL] [Abstract][Full Text] [Related]
55. Nanoarchitecture Based SERS for Biomolecular Fingerprinting and Label-Free Disease Markers Diagnosis.
Sinha SS; Jones S; Pramanik A; Ray PC
Acc Chem Res; 2016 Dec; 49(12):2725-2735. PubMed ID: 27993003
[TBL] [Abstract][Full Text] [Related]
56. Tailored point-of-care biosensors for liquid biopsy in the field of oncology.
Singh S; Podder PS; Russo M; Henry C; Cinti S
Lab Chip; 2022 Dec; 23(1):44-61. PubMed ID: 36321747
[TBL] [Abstract][Full Text] [Related]
57. Material design, development, and trend for surface-enhanced Raman scattering substrates.
Ying Y; Tang Z; Liu Y
Nanoscale; 2023 Jul; 15(26):10860-10881. PubMed ID: 37335252
[TBL] [Abstract][Full Text] [Related]
58. Emerging SERS biosensors for the analysis of cells and extracellular vesicles.
Tavakkoli Yaraki M; Tukova A; Wang Y
Nanoscale; 2022 Oct; 14(41):15242-15268. PubMed ID: 36218172
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.
Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; López-López R; Muinelo-Romay L; Diaz-Lagares A
Front Cell Dev Biol; 2021; 9():622459. PubMed ID: 33614651
[TBL] [Abstract][Full Text] [Related]
60. Controlling the Nucleation and Growth of Salt from Bodily Fluid for Enhanced Biosensing Applications.
Srivastava S; Terai Y; Liu J; Capellini G; Xie YH
Biosensors (Basel); 2023 Dec; 13(12):. PubMed ID: 38131777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
